Inhibition of P-glycoprotein by cyclosporin A analogues and metabolites

被引:12
作者
Demeule, M
Laplante, A
Sepehr-Araé, A
Beaulieu, É
Averill-Bates, D
Wenger, RM
Béliveau, R
机构
[1] Univ Quebec, Mol Med Lab, Grp Rech Transport Membranaire, Montreal, PQ H3C 3P8, Canada
[2] Hop St Justine, Ctr Oncol Charles Bruneau, Montreal, PQ H3T 1C5, Canada
[3] Univ Quebec, Dept Chim Biochim, Montreal, PQ H3C 3P8, Canada
[4] Novartis Pharmaceut, CH-4202 Basel, Switzerland
关键词
P-glycoprotein; cyclosporin A; vinblastine uptake; photolabeling; ATPase activity;
D O I
10.1139/bcb-77-1-47
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction between P-glycoprotein (P-gp) from membranes isolated from multidrug-resistant Chinese hamster ovary cells and cyclosporin A (CsA) analogues and its metabolites was characterized. Screening of these latter as chemosensitizers was performed using three different assays: (i) vinblastine uptake, (ii) photoaffinity labeling by [I-125]iodoaryl azidoprazosin, and (iii) P-gp ATPase activity. Oxidation of the hydroxyl group at position I of CsA (200-096), CsG (215-834), or CsD (PSC-833) increased their inhibition of P-gp. CsA analogues (208-032, 208-183) modified at position 11 retained their ability to inhibit P-gp while analogues modified at position 2 (CsC and CsD) lost their efficiency. The inhibitions induced by metabolites of CsA were also compared to those obtained with CsG metabolites. From all the molecules tested, PSC-833 and 280-446 peptolide were the strongest inhibitors. Our results indicate that modifications of CsA analogues at position 1 and 2 are critical for their interaction with P-gp and that CsA. metabolites retain a portion of the inhibitory activity of the parent drug.
引用
收藏
页码:47 / 58
页数:12
相关论文
共 50 条
[1]  
AKAGI H, 1991, J INT MED RES, V19, P1
[2]   PARTIAL-PURIFICATION AND RECONSTITUTION OF THE HUMAN MULTIDRUG-RESISTANCE PUMP - CHARACTERIZATION OF THE DRUG-STIMULATABLE ATP HYDROLYSIS [J].
AMBUDKAR, SV ;
LELONG, IH ;
ZHANG, JP ;
CARDARELLI, CO ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) :8472-8476
[3]  
ArchinalMattheis A, 1995, ONCOL RES, V7, P603
[4]   TRANSPORT STUDIES WITH BRUSH-BORDER MEMBRANE-VESICLES - CHOICE OF EXPERIMENTAL PARAMETERS [J].
BELIVEAU, R ;
DEMEULE, M ;
STREVEY, J .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1989, 21 (09) :955-960
[5]   EXTENT AND PERSISTENCE OF P-GLYCOPROTEIN INHIBITION IN MULTIDRUG-RESISTANT P388 CELLS AFTER EXPOSURE TO RESISTANCE-MODIFYING AGENTS [J].
BOESCH, D ;
LOOR, F .
ANTI-CANCER DRUGS, 1994, 5 (02) :229-238
[6]  
BOESCH D, 1991, CANCER RES, V51, P4226
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   DIFFERENTIAL INTERACTION OF HUMAN RENAL P-GLYCOPROTEIN WITH VARIOUS METABOLITES AND ANALOGS OF CYCLOSPORINE-A [J].
CHARUK, JHM ;
WONG, PY ;
REITHMEIER, RAF .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 269 (01) :F31-F39
[9]   INTERNAL DUPLICATION AND HOMOLOGY WITH BACTERIAL TRANSPORT PROTEINS IN THE MDR1 (P-GLYCOPROTEIN) GENE FROM MULTIDRUG-RESISTANT HUMAN-CELLS [J].
CHEN, CJ ;
CHIN, JE ;
UEDA, K ;
CLARK, DP ;
PASTAN, I ;
GOTTESMAN, MM ;
RONINSON, IB .
CELL, 1986, 47 (03) :381-389
[10]   Molecular interactions of cyclosporin A with P-glycoprotein - Photolabeling with cyclosporin derivatives [J].
Demeule, M ;
Wenger, RM ;
Beliveau, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) :6647-6652